Use of GABA agonists for the treatment of spastic disorders, convulsions, epilepsy, and neuroprotection
AssigneeThe UAB Research Foundation
InventorsJay Meythaler, Jean Peduzzi
Life of this patent
Estimating the term…
Abstract
A method of treating a neuronal disorder is provided that includes the intravenous administration to a subject suffering or predisposed to a neuronal disorder a therapeutically effective amount of gamma-aminobutyramide or a pharmaceutically acceptable salt thereof. Gamma-aminobutyramide has sufficient stability for intravenous administration and is able to cross the blood-brain barrier. A method of neuroprotection is provided that includes administration to a subject suffering or predisposed to a neuronal disorder associated with spasticity or convulsions a therapeutically effective amount of gamma-aminobutyramide or a pharmaceutically acceptable salt thereof.
Claims11
A method of treating a neuronal disorder comprising administering intravenously to a subject suffering or predisposed to the neuronal disorder a therapeutically effective amount of gamma-aminobutyramide or a pharmaceutically acceptable salt.
A method of neuroprotection comprising administering to a subject suffering or predisposed to a neuronal disorder having associated therewith a symptom selected from the group consisting of spasticity and convulsions a therapeutically effective amount of gamma-aminobutyramide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.